| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 81, 1312-1317, Copyright © 1996 by Endocrine Society
ARTICLES |
H Health 3rd, S Odelberg, CE Jackson, BT Teh, N Hayward, C Larsson, NR Buist, KJ Krapcho, BC Hung, IV Capuano, JE Garrett and MF Leppert
Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, 84132, USA.
The predominant variety of familial benign hypocalciuric hypercalcemia (FBHH) is FBHH(3q), which is associated with presumed inactivating mutations of the cell surface calcium receptor (CaR) gene on chromosome 3q13.3-q21. We sought mutations of the CaR gene in FBHH by direct sequencing of PCR-amplified genomic DNA from 14 affected families: 8 mapped to 3q13, 1 mapped to chromosome 19p, and 5 unmapped. We sequenced the entire coding region of the gene (exons 2-7) in one or two affected members of each family and found six point mutations that altered one amino acid, cosegregated with hypercalcemia, and were absent in more than 100 unaffected persons. Four mutations were unique (S53P, D215G, S657Y, and P748R), and two had been reported previously (P55L and R185Q). Of four mutant CaR proteins expressed in Xenopus oocytes, three were deficient in extracellular Ca2+-induced signaling. No CaR mutations were found in eight families, including the one mapped to chromosome 19p. Three benign polymorphisms occurred in the COOH- terminal region of the CaR protein in 10%, 15%, and 30% of more than 100 unaffected persons. Thus, FBHH-causing CaR mutations were clustered in the NH2-terminal extracellular and membrane-spanning regions of the receptor protein. We suggest that these are important functional domains, probably for calcium binding and signal transduction, respectively. Finally, mutations in regulatory or intronic regions of the CaR gene may also underlie many cases of FBHH.
This article has been cited by other articles:
![]() |
J. Y. L. Lu, Y. Yang, G. Gnacadja, A. Christopoulos, and J. D. Reagan Effect of the Calcimimetic R-568 [3-(2-Chlorophenyl)-N-((1R)-1-(3-methoxyphenyl)ethyl)-1-propanamine] on Correcting Inactivating Mutations in the Human Calcium-Sensing Receptor J. Pharmacol. Exp. Ther., December 1, 2009; 331(3): 775 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. White, J. McKenna, A. Cavanaugh, and G. E. Breitwieser Pharmacochaperone-Mediated Rescue of Calcium-Sensing Receptor Loss-of-Function Mutants Mol. Endocrinol., July 1, 2009; 23(7): 1115 - 1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E C Cole, F. H J Yun, B. Y L Wong, A. Y Shuen, R. A Booth, A. Scillitani, S. Pidasheva, X. Zhou, L. Canaff, and G. N Hendy Calcium-sensing receptor mutations and denaturing high performance liquid chromatography J. Mol. Endocrinol., April 1, 2009; 42(4): 331 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zajickova, J. Vrbikova, L. Canaff, P. D. Pawelek, D. Goltzman, and G. N. Hendy Identification and Functional Characterization of a Novel Mutation in the Calcium-Sensing Receptor Gene in Familial Hypocalciuric Hypercalcemia: Modulation of Clinical Severity by Vitamin D Status J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2616 - 2623. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Marz, U. Seelhorst, B. Wellnitz, B. Tiran, B. Obermayer-Pietsch, W. Renner, B. O. Boehm, E. Ritz, and M. M. Hoffmann Alanine to Serine Polymorphism at Position 986 of the Calcium-Sensing Receptor Associated with Coronary Heart Disease, Myocardial Infarction, All-Cause, and Cardiovascular Mortality J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2363 - 2369. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Scillitani, V. Guarnieri, C. Battista, S. De Geronimo, L. A. Muscarella, I. Chiodini, M. Cignarelli, S. Minisola, F. Bertoldo, C. M. Francucci, et al. Primary Hyperparathyroidism and the Presence of Kidney Stones Are Associated with Different Haplotypes of the Calcium-Sensing Receptor J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 277 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Corbetta, C Eller-Vainicher, M Filopanti, P Saeli, G Vezzoli, T Arcidiacono, P Loli, M L Syren, L Soldati, P Beck-Peccoz, et al. R990G polymorphism of the calcium-sensing receptor and renal calcium excretion in patients with primary hyperparathyroidism. Eur. J. Endocrinol., November 1, 2006; 155(5): 687 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wystrychowski, S. Pidasheva, L. Canaff, J. Chudek, F. Kokot, A. Wiecek, and G. N. Hendy Functional Characterization of Calcium-Sensing Receptor Codon 227 Mutations Presenting as Either Familial (Benign) Hypocalciuric Hypercalcemia or Neonatal Hyperparathyroidism J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 864 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Peters, N. Chatterjee, M. Yeager, S. J. Chanock, R. E. Schoen, K. A. McGlynn, T. R. Church, J. L. Weissfeld, A. Schatzkin, and R. B. Hayes Association of Genetic Variants in the Calcium-Sensing Receptor with Risk of Colorectal Adenoma Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2181 - 2186. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Scillitani, V. Guarnieri, S. De Geronimo, L. A. Muscarella, C. Battista, L. D'Agruma, F. Bertoldo, C. Florio, S. Minisola, G. N. Hendy, et al. Blood Ionized Calcium Is Associated with Clustered Polymorphisms in the Carboxyl-Terminal Tail of the Calcium-Sensing Receptor J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5634 - 5638. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Warner, M Epstein, A Sweet, D Singh, J Burgess, S Stranks, P Hill, D Perry-Keene, D Learoyd, B Robinson, et al. Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications J. Med. Genet., March 1, 2004; 41(3): 155 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Simonds, C. M. Robbins, S. K. Agarwal, G. N. Hendy, J. D. Carpten, and S. J. Marx Familial Isolated Hyperparathyroidism Is Rarely Caused by Germline Mutation in HRPT2, the Gene for the Hyperparathyroidism-Jaw Tumor Syndrome J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 96 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Kifor, F. D. Moore Jr., M. Delaney, J. Garber, G. N. Hendy, R. Butters, P. Gao, T. L. Cantor, I. Kifor, E. M. Brown, et al. A Syndrome of Hypocalciuric Hypercalcemia Caused by Autoantibodies Directed at the Calcium-Sensing Receptor J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 60 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Canaff and G. N. Hendy Human Calcium-sensing Receptor Gene. VITAMIN D RESPONSE ELEMENTS IN PROMOTERS P1 AND P2 CONFER TRANSCRIPTIONAL RESPONSIVENESS TO 1,25-DIHYDROXYVITAMIN D J. Biol. Chem., August 9, 2002; 277(33): 30337 - 30350. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nagase, T. Murakami, T. Tsukada, R. Kitamura, N. Chikatsu, H. Takeo, N. Takata, H. Yasuda, S. Fukumoto, Y. Tanaka, et al. A Family of Autosomal Dominant Hypocalcemia with a Positive Correlation between Serum Calcium and Magnesium: Identification of a Novel Gain of Function Mutation (Ser820Phe) in the Calcium-Sensing Receptor J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2681 - 2687. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D'Souza-Li, B. Yang, L. Canaff, M. Bai, D. A. Hanley, M. Bastepe, S. R. Salisbury, E. M. Brown, D. E. C. Cole, and G. N. Hendy Identification and Functional Characterization of Novel Calcium-Sensing Receptor Mutations in Familial Hypocalciuric Hypercalcemia and Autosomal Dominant Hypocalcemia J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1309 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-S. Jap, Y.-C. Wu, S.-F. Jenq, and G.-S. Won A Novel Mutation in the Calcium-Sensing Receptor Gene in a Chinese Subject with Persistent Hypercalcemia and Hypocalciuria J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 13 - 15. [Abstract] [Full Text] |
||||
![]() |
L.-J. Dai, G. Ritchie, D. Kerstan, H. S. Kang, D. E. C. Cole, and G. A. Quamme Magnesium Transport in the Renal Distal Convoluted Tubule Physiol Rev, January 1, 2001; 81(1): 51 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Brown and R. J. MacLeod Extracellular Calcium Sensing and Extracellular Calcium Signaling Physiol Rev, January 1, 2001; 81(1): 239 - 297. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Carling, E. Szabo, M. Bai, P. Ridefelt, G. Westin, P. Gustavsson, S. Trivedi, P. Hellman, E. M. Brown, N. Dahl, et al. Familial Hypercalcemia and Hypercalciuria Caused by a Novel Mutation in the Cytoplasmic Tail of the Calcium Receptor J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 2042 - 2047. [Abstract] [Full Text] |
||||
![]() |
N. Chikatsu, S. Fukumoto, Y. Takeuchi, M. Suzawa, T. Obara, T. Matsumoto, and T. Fujita Cloning and Characterization of Two Promoters for the Human Calcium-sensing Receptor (CaSR) and Changes of CaSR Expression in Parathyroid Adenomas J. Biol. Chem., March 10, 2000; 275(11): 7553 - 7557. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Okazaki, N. Chikatsu, M. Nakatsu, Y. Takeuchi, M. Ajima, J. Miki, T. Fujita, M. Arai, Y. Totsuka, K. Tanaka, et al. A Novel Activating Mutation in Calcium-Sensing Receptor Gene Associated with a Family of Autosomal Dominant Hypocalcemia J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 363 - 366. [Abstract] [Full Text] |
||||
![]() |
Y. Oda, C.-L. Tu, S. Pillai, and D. D. Bikle The Calcium Sensing Receptor and Its Alternatively Spliced Form in Keratinocyte Differentiation J. Biol. Chem., September 4, 1998; 273(36): 23344 - 23352. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Farnebo, U. Enberg, L. Grimelius, M. Backdahl, M. Schalling, C. Larsson, and L.-O. Farnebo Tumor-Specific Decreased Expression of Calcium Sensing Receptor Messenger Ribonucleic Acid in Sporadic Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3481 - 3486. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kobayashi, H. Tanaka, K. Tsuzuki, M. Tsuyuki, H. Igaki, Y. Ichinose, K. Aya, N. Nishioka, and Y. Seino Two Novel Missense Mutations in Calcium-Sensing Receptor Gene Associated with Neonatal Severe Hyperparathyroidism J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2716 - 2719. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H.S. Pearce, C. Williamson, O. Kifor, M. Bai, M. G. Coulthard, M. Davies, N. Lewis-Barned, D. McCredie, H. Powell, P. Kendall-Taylor, et al. A Familial Syndrome of Hypocalcemia with Hypercalciuria Due to Mutations in the Calcium-Sensing Receptor N. Engl. J. Med., October 10, 1996; 335(15): 1115 - 1122. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bai, S. Quinn, S. Trivedi, O. Kifor, S. H.S. Pearce, M. R. Pollak, K. Krapcho, S. C. Hebert, and E. M. Brown Expression and Characterization of Inactivating and Activating Mutations in the Human Ca2+o-sensing Receptor J. Biol. Chem., August 9, 1996; 271(32): 19537 - 19545. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Canaff, J.-L. Petit, M. Kisiel, P. H. Watson, M. Gascon-Barre, and G. N. Hendy Extracellular Calcium-sensing Receptor Is Expressed in Rat Hepatocytes. COUPLING TO INTRACELLULAR CALCIUM MOBILIZATION AND STIMULATION OF BILE FLOW J. Biol. Chem., February 2, 2001; 276(6): 4070 - 4079. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |